Get the Stockscreener App
43.62
0.71%
-0.31
Pre-market:
43.62
Tempus Ai Inc stock is traded at $43.62, with a volume of 5.64M.
It is down -0.71% in the last 24 hours and down -21.93% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$43.93
Open:
$44.1
24h Volume:
5.64M
Relative Volume:
1.01
Market Cap:
$7.83B
Revenue:
$1.36B
Net Income/Loss:
$-302.91M
P/E Ratio:
-25.39
EPS:
-1.7182
Net Cash Flow:
$-219.93M
1W Performance:
-9.99%
1M Performance:
-21.93%
6M Performance:
-34.67%
1Y Performance:
-33.39%
1-Day Range:
$43.13
$45.72
1-Week Range:
$43.13
$48.13
52-Week Range:
$41.73
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
43.62 | 7.89B | 1.36B | -302.91M | -219.93M | -1.7182 |
VEEV
Veeva Systems Inc
|
163.85 | 25.93B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
56.18 | 11.23B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
83.04 | 6.89B | 1.31B | 215.20M | 408.32M | 2.4627 |
HNGE
Hinge Health Inc
|
54.71 | 4.22B | 646.34M | -512.40M | 202.76M | -6.6871 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-13-26 | Initiated | Jefferies | Underperform |
| Apr-13-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
Assessing Tempus AI (TEM) Valuation After Recent Share Price Weakness - Yahoo Finance
Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts - Yahoo Finance
ARK Invest Increases AI and Genomic Holdings While Reducing Semi - GuruFocus
Tempus AI And BMS Deepen AI Drug Development Ties As Losses Persist - Yahoo Finance
How Beaten-Down Tempus AI Stock Offers a Lottery Ticket for Traders Here - Barchart.com
7 Healthcare AI Stocks Under $50 With Huge Upside Potential - 24/7 Wall St.
Cathie Wood’s weekly update: buys Cerebras, Tempus AI, sells AMD and TSM (ARKK:BATS) - Seeking Alpha
Tempus AI, Inc. Class A Common Stock (TEM) Live Share Price, Invest From India - INDmoney
Tempus AI stock jumps, ALERT trial results boost EHR automation buzz - MSN
Tempus AI stock gains following the ALERT trial result announcement - MSN
Cathie Wood buys $14.9 million of Tempus AI stock - MSN
Tempus AI Inc (TEM) Stock Price, Quote, News & History - Benzinga
Tempus AI (TEM) executive Fukushima Ryan makes bona fide stock gifts under lock-up - Stock Titan
HIMS Stock Dips 14.3% Since Q1 Earnings: Should You Still Hold or Sell? - TradingView
Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Tempus AI shares gain after expanded partnership with Gilead - MSN
Alzheimer’s Blood-Based Biomarker Testing Integrated into Clinical Workflows - Clinical Lab Products
Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience - Quantisnow
Tempus AI Stock (TEM) Opinions on Bristol Myers Squibb Partnership Expansion - Quiver Quantitative
Here’s Why Aristotle Core Equity Fund Bets on Tempus AI (TEM), a Healthcare Technology Company - Insider Monkey
AI aims to reshape Bristol Myers’ cancer and Alzheimer’s drug trials - Stock Titan
Baillie Gifford Reduces Stake in Tempus AI Inc: A Strategic Port - GuruFocus
Tempus AI Announces $350M Convertible Senior Notes Offering to Repay Debt and Enhance Financial Flexibility - Minichart
Tempus AI Completes Convertible Notes Offering, Retires Secured Debt - TipRanks
Tempus AI Prices $460 Million 0% Convertible Notes Due 2032, Retires Senior Credit Facility - TradingView
AI In Medical Imaging Market Expected to Witness Rapid Expansion - openPR.com
TEM Stock Price, Quote & Chart | TEMPUS AI INC-CL A (NASDAQ:TEM) - ChartMill
Tempus AI (NASDAQ: TEM) prices $460M 0% 2032 convertible notes and repays debt - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
Piper Sandler Maintains Tempus AI(TEM.US) With Hold Rating, Maintains Target Price $58 - Moomoo
Ark Invest Again Sells AMD, This Time As Stock Hits 52-Week High While Snapping Up Tempus AI And Circle - Benzinga
Cathie Wood’s ARK sells AMD stock, buys Kratos and Tempus AI - Investing.com
Tempus AI prices upsized $400M offering - MSN
Artificial Intelligence Stocks Worth WatchingMay 11th - MarketBeat
How Lucent and Tempus Are Using AI to Spot Alzheimer’s Earlier - HIT Consultant
H.C. Wainwright cuts Tempus AI stock price target to $64 on wider losses By Investing.com - Investing.com Australia
H.C. Wainwright cuts Tempus AI stock price target to $64 on wider losses - Investing.com UK
H.C. Wainwright Maintains Tempus AI(TEM.US) With Buy Rating, Cuts Target Price to $64 - Moomoo
Digital tool that flags high-risk patients wins global health tech award - Stock Titan
Tempus AI, Inc. (TEM) Stock Analysis: Exploring The 38.92% Potential Upside For Investors - DirectorsTalk Interviews
Cathie Wood Dumps Another $3 Million In AMD Stock As Ark Invest Trims For Third Day Running, This Is the AI Stock She Is Buying Instead - Yahoo Finance
Tempus AI (TEM) Valuation Check As Q1 2026 Growth And New Pharma Collaborations Refocus Attention - simplywall.st
Tempus AI Raises US$400m As Alzheimer’s Collaboration Broadens Diagnostic Reach - Sahm
Lucent Diagnostics and Tempus AI partner to expand access to Alzheimer’s blood biomarker testing - SelectScience
Top Artificial Intelligence Stocks To ResearchMay 10th - MarketBeat
Is Tempus AI (TEM) The Best AI Healthcare Stock to Buy? - Insider Monkey
Tempus AI targets $1.59B-$1.6B revenue and about $65M adjusted EBITDA in 2026, backed by Merck collaboration - MSN
Tempus AI plans $350M convertible notes offering - MSN
BTIG Maintains Tempus AI (TEM) Buy Recommendation - MSN
Tempus AI Expands Beyond Oncology With New Alzheimer’s Blood Test Alliance - Yahoo Finance
Tempus AI (TEM) reports Q1 loss, beats revenue estimates - MSN
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.06%
2.97%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):